This compound is a chiral bicyclic amine used as a pharmaceutical intermediate in the manufacturing of moxifloxacin. It features a saturated heterocyclic ring system with two amine groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 151213-42-2
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
pharmaceutical intermediate
2-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride
pharmaceutical intermediate
2,3-Difluoropyridine
pharmaceutical intermediate
Cyanocobalamin-e-methylamide
pharmaceutical intermediate
Methyl chlorodifluoroacetate
pharmaceutical intermediate
(4aS,7aR)-Octahydro-1H-pyrrolo[3,4-b]pyridine
research compound
(4aS,7aR)-Octahydro-1H-pyrrolo[3,4-b]pyridine
research compound
(S,S)-2,8-Diazabicyclo[4.3.0]nonane
pharmaceutical intermediate
(4aR,7aR)-2,3,4,4a,5,6,7,7a-octahydro-1H-pyrrolo[3,4-b]pyridine
KSCPLKVBWDOSAI-RQJHMYQMSA-N
C1C[C@@H]2CNC[C@@H]2NC1